Partnership pairs CellFiber’s proprietary hollow-fiber encapsulation platform with Tidewave Bio’s universal, off-the-shelf cell immunotherapy program in a proof-of-concept process evaluation ...

The market is anticipated to generate an incremental opportunity of USD 17.0 billion between 2026 and 2036. Increasing late-stage clinical programs, rising demand for contract development and manufact ...

It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the US approval of three cell therapy products: Iovance ...

How can data and artificial intelligence transform the battery cell production of tomorrow? This is the question addressed by the joint project KiBa-Pro, ...

HKSTP Hosts Showcase Featuring Clinical Progress from 10 Park Companies and Real-Life Patient StoriesHONG KONG SAR - ...

SINGAPORE - Media OutReach Newswire - 4 August 2026 -Singapore is estimated to record approximately 19,290 new cancer cases in 2024, underscoring the growing demand for advanced treatment options and ...

Earlier this week, contract development and manufacturing organization (CDMO) Cellares announced its partnership with ...

At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...

Cell and gene therapy manufacturers are partnering with specialist technology companies to address the challenges associated with scaling complex therapies.